SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regeneron Pharmaceuticals Inc.PRNewsWire • 08/20/20
Regeneron Teaming With Roche On Coronavirus Treatment; Adds CapacityInvestors Business Daily • 08/19/20
Regeneron To Collaborate With Roche For Global Supply Of Its Coronavirus TreatmentBenzinga • 08/19/20
Roche and Regeneron collaborate to significantly increase global supply of REGN-COV2 investigational antibody combination for COVID-19GlobeNewsWire • 08/19/20
Genentech and Regeneron Collaborate to Significantly Increase Global Supply of REGN-COV2 Investigational Antibody Combination for COVID-19Business Wire • 08/19/20
FDA Accepts Evinacumab Biologics License Application for Priority Review as a Treatment for Patients with HoFH, an Ultra-rare Inherited Form of High CholesterolPRNewsWire • 08/12/20
Regeneron Pharmaceuticals, Inc. (REGN) CEO Leonard Schleifer on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/05/20